Biomarker changes during acute heart failure treatment

Congestive Heart Failure, 05/04/2012

In this preliminary study, patients with ADHF had measurable changes in MR–proANP, MR–proADM, and CT–pro–ET–1 24 hours after initial therapy. A study of association with clinical course and outcomes to determine the role of these markers in risk–stratification is warranted.

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List